440 related articles for article (PubMed ID: 33358076)
21. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
[TBL] [Abstract][Full Text] [Related]
22. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
[TBL] [Abstract][Full Text] [Related]
23. Breast Implant-associated Anaplastic Large Cell Lymphoma.
Alotaibi S; Hamadani M; Al-Mansour M; Aljurf M
Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e272-e276. PubMed ID: 33384263
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
Fleming D; Stone J; Tansley P
Aesthetic Plast Surg; 2020 Aug; 44(4):1109-1115. PubMed ID: 32766915
[TBL] [Abstract][Full Text] [Related]
25. Breast implant-associated anaplastic large cell lymphoma: emotional impact and guidelines for psychological support.
Oliveri S; Ongaro G; Durosini I; Curigliano G; Pravettoni G
Breast Cancer Res Treat; 2020 May; 181(1):221-224. PubMed ID: 32232699
[TBL] [Abstract][Full Text] [Related]
26. How Breast Implant Surface Type Is Influenced by Breast Implant-associated Anaplastic Large Cell Lymphoma: A Survey of the American Society of Plastic Surgeons.
Carr LW; Roberts J; Potochny JD
Ann Plast Surg; 2019 Apr; 82(4S Suppl 3):S208-S211. PubMed ID: 30855390
[TBL] [Abstract][Full Text] [Related]
27. Clinical Implications and Management of Non-BIA-ALCL Breast Implant Capsular Pathology.
Vorstenbosch J; Chu JJ; Ariyan CE; McCarthy CM; Disa JJ; Nelson JA
Plast Reconstr Surg; 2023 Jan; 151(1):20e-30e. PubMed ID: 36194076
[TBL] [Abstract][Full Text] [Related]
28. Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL.
Longo B; Di Napoli A; Curigliano G; Veronesi P; Pileri S; Martelli M; De Vita R; Felici N; Cirillo P; Bernardi C; D'orsi G; Giacalone M; Storti G; Cervelli V
Breast; 2022 Dec; 66():332-341. PubMed ID: 36502569
[TBL] [Abstract][Full Text] [Related]
29. MRI features of breast implant-associated anaplastic large cell lymphoma.
Rotili A; Ferrari F; Nicosia L; Pesapane F; Tabanelli V; Fiori S; Vanazzi A; Meneghetti L; Abbate F; Latronico A; Cassano E
Br J Radiol; 2021 Sep; 94(1125):20210093. PubMed ID: 33989039
[TBL] [Abstract][Full Text] [Related]
30. Cytological Diagnosis of Bilateral Breast Implant-Associated Lymphoma of the ALK-Negative Anaplastic Large-Cell Type. Clinical Implications of Peri-Implant Breast Seroma Cytological Reporting.
Granados R; Lumbreras EM; Delgado M; Aramburu JA; Tardío JC
Diagn Cytopathol; 2016 Jul; 44(7):623-7. PubMed ID: 27079579
[TBL] [Abstract][Full Text] [Related]
31. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
Kadin ME; Adams WP; Inghirami G; Di Napoli A
Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
[TBL] [Abstract][Full Text] [Related]
32. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Two Distinct Clinical Presentations.
Miranda P; Moita F; Vargas Moniz J; Rodrigues Dos Santos C
Acta Med Port; 2022 Nov; 35(11):835-839. PubMed ID: 35584637
[TBL] [Abstract][Full Text] [Related]
33. Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?
Kadin ME; Xu H; Hunsicker LM; Guan Y
Aesthet Surg J; 2022 Jan; 42(2):NP125-NP129. PubMed ID: 33944901
[TBL] [Abstract][Full Text] [Related]
34. Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines.
Lillemoe HA; Miranda RN; Nastoupil LJ; Clemens MW; Hunt KK
Ann Surg Oncol; 2022 Sep; 29(9):5722-5729. PubMed ID: 35597841
[TBL] [Abstract][Full Text] [Related]
35. NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Clemens MW; Horwitz SM
Aesthet Surg J; 2017 Mar; 37(3):285-289. PubMed ID: 28184418
[TBL] [Abstract][Full Text] [Related]
36. 2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Clemens MW; Jacobsen ED; Horwitz SM
Aesthet Surg J; 2019 Jan; 39(Suppl_1):S3-S13. PubMed ID: 30715173
[TBL] [Abstract][Full Text] [Related]
37. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies.
Naga HI; Mellia JA; Basta MN; Morris MP; Christopher AN; Campbell FM; Sommers K; Levinson H; Nelson JA; Fischer JP
Plast Reconstr Surg; 2022 Oct; 150(4):762-769. PubMed ID: 35862104
[TBL] [Abstract][Full Text] [Related]
38. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Oishi N; Miranda RN; Feldman AL
Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
Fleming D; Stone J; Tansley P
Aesthetic Plast Surg; 2018 Jun; 42(3):672-678. PubMed ID: 29445921
[TBL] [Abstract][Full Text] [Related]
40. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
